Efficacy of B cell depletion therapy for murine joint arthritis flare is associated with increased lymphatic flow

Updated consensus statement on the use of rituximab in patients with rheumatoid arthritis

(2011) M. H. Buch et al.   ANNALS OF THE RHEUMATIC DISEASES

Response to rituximab in patients with rheumatoid arthritis in different compartments of the immune system

(2011) Maria J. H. Boumans et al.   ARTHRITIS AND RHEUMATISM

Inflammation and autoantibody markers identify rheumatoid arthritis patients with enhanced clinical benefit following rituximab treatment

(2011) Preeti Lal et al.   ARTHRITIS AND RHEUMATISM

Targeting joint lymphatic function

(2011) Jenny Buckland   Nature Reviews Rheumatology

Impaired lymphatic contraction associated with immunosuppression

(2011) S. Liao et al.   PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA

Subclinical remodelling of draining lymph node structure in early and established rheumatoid arthritis assessed by power Doppler ultrasonography

(2011) A. Manzo et al.   RHEUMATOLOGY

CD23+/CD21hi B-cell translocation and ipsilateral lymph node collapse is associated with asymmetric arthritic flare in TNF-Tg mice

(2011) Jie Li et al.   ARTHRITIS RESEARCH & THERAPY

Lymphatic system: a vital link between metabolic syndrome and inflammation

(2010) Sanjukta Chakraborty et al.   Annals of the New York Academy of Sciences

Efficacy and safety of different doses and retreatment of rituximab: a randomised, placebo-controlled trial in patients who are biological naive with active rheumatoid arthritis and an inadequate response to methotrexate (Study Evaluating Rituximab's Efficacy in MTX iNadequate rEsponders (SERENE))

(2010) P. Emery et al.   ANNALS OF THE RHEUMATIC DISEASES

Inhibition of joint damage and improved clinical outcomes with rituximab plus methotrexate in early active rheumatoid arthritis: the IMAGE trial

(2010) P. P. Tak et al.   ANNALS OF THE RHEUMATIC DISEASES

Expanded CD23+/CD21hi B Cells in Inflamed Lymph Nodes Are Associated with the Onset of Inflammatory-Erosive Arthritis in TNF-Transgenic Mice and Are Targets of Anti-CD20 Therapy

(2010) J. Li et al.   JOURNAL OF IMMUNOLOGY

Inhibition of lymphangiogenesis and lymphatic drainage via vascular endothelial growth factor receptor 3 blockade increases the severity of inflammation in a mouse model of chronic inflammatory arthritis

(2009) Ruolin Guo et al.   ARTHRITIS AND RHEUMATISM

Profiling of rheumatoid arthritis associated autoantibodies

(2009) Karsten Conrad et al.   AUTOIMMUNITY REVIEWS

Rituximab treatment in rheumatoid arthritis: how does it work?

(2009) Maria JH Boumans et al.   ARTHRITIS RESEARCH & THERAPY

Molecular Regulation of Lymphatic Contractility

(2008) Mariappan Muthuchamy et al.   Annals of the New York Academy of Sciences

Rituximab inhibits structural joint damage in patients with rheumatoid arthritis with an inadequate response to tumour necrosis factor inhibitor therapies

(2008) E Keystone et al.   ANNALS OF THE RHEUMATIC DISEASES

Elucidating bone marrow edema and myelopoiesis in murine arthritis using contrast‐enhanced magnetic resonance imaging

(2008) Steven T. Proulx et al.   ARTHRITIS AND RHEUMATISM

The Lymphatic System in Health and Disease

(2008) Leah N. Cueni et al.   Lymphatic Research and Biology

Elevated autoantibody content in rheumatoid arthritis synovia with lymphoid aggregates and the effect of rituximab

(2008) Sanna Rosengren et al.   ARTHRITIS RESEARCH & THERAPY